Menstrual management using the etonogestrel implant in individuals with intellectual disabilities in Joinville, Brazil
International Journal of Gynecology & Obstetrics · 2025
DOI: 10.1002/ijgo.15930 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Giordana Campo Braga und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Ribeirao Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil. Hauptthemen laut MEDLINE: Desogestrel, Contraceptive Agents, Female, Intellectual Disability, Menstruation. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Objective
This study aimed to describe the use of etonogestrel (ENG) implants for menstrual management (i.e., management of bleeding and symptoms associated with menstruation) in individuals with intellectual disabilities.
Methods
This study retrospectively analyzed a cohort of individuals with intellectual disabilities who began using ENG implants between 2003 and 2018, in Joinville, Brazil. We collected sociodemographic, clinical, and reproductive data from the medical records, along with information related to ENG implant use.
Results
In total, 369 implants were placed in 130 individuals with intellectual disabilities. The median age at the first implant was 20 (interquartile range [IQR], 17–26) years, and 43.8% of the patients were adolescents. By December 2018, 90 patients had received two or more subsequent implants. The median duration of current ENG implant use was 19 (IQR, 12.8–22) months. More than 40% of the patients had comorbidities, with epilepsy being the most common. During the use of the current implant, 80% of the patients had a favorable bleeding profile (no bleeding or ≤1 bleeding episode per month), and 53.8% (70/130) had no bleeding within 3 months before their last medical visit. Among patients experiencing dysmenorrhea and premenstrual syndrome (PMS), 79% (64/81) and 82% (54/66) reported complete improvement, respectively. The premature implant removal rate was 8.9% (33/369). Unfavorable bleeding was the main reason for premature implant removal (20 out 33 removals).
Conclusions
ENG implants might be a suitable option for individuals with intellectual disabilities who require management of menstrual bleeding and symptoms associated with menstruation. Most patients had a favorable bleeding profile and experienced significant improvements in dysmenorrhea and PMS, contributing to the high continuation rates of ENG implants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Ribeirao Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.
- Department of Social Medicine, Ribeirao Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.
- Núcleo de Assistência Integral ao Paciente Especial, Joinvile, SC, Brazil.
ORCID-Profile: Giordana Campo Braga
Zitieren
APA
Braga, G. C., Zarabia, C. J., da Trindade, A. K. S. S., & Vieira, C. S. (2025). Menstrual management using the etonogestrel implant in individuals with intellectual disabilities in Joinville, Brazil. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.15930
Vancouver
Braga GC, Zarabia CJ, da Trindade AKSS, Vieira CS. Menstrual management using the etonogestrel implant in individuals with intellectual disabilities in Joinville, Brazil. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.15930
BibTeX
@article{Braga2025,
author = {Braga, Giordana Campo and Zarabia, Carla Josene and da Trindade, Adriana Kelly Soares de S and Vieira, Carolina Sales},
title = {Menstrual management using the etonogestrel implant in individuals with intellectual disabilities in Joinville, Brazil},
journal = {International Journal of Gynecology & Obstetrics},
year = {2025},
doi = {10.1002/ijgo.15930}
}
EUVIMED